New compound ZTA-26 could be a game-changer in lipid metabolism regulation

Scientists at Nagoya University in Japan have made a significant breakthrough in treating lipid disorders.

Paxlovid didn’t shorten Covid symptoms in vaccinated adults, full trial results confirm

“If it’s Covid, Paxlovid.” That’s how Pfizer markets its Covid-19 antiviral, even as the full results of a study published in the New England Journal

April 5, 2024

Alnylam reveals positive Phase III results for rare heart disease drug vutrisiran – Pharmaceutical Technology

RNAi therapeutic, vutrisiran is FDA approved for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis (ATTR) in adults and is sold under the brand name

June 24, 2024

AI-Massage Powered by Robotics: Redefining Healthcare and Wellness

Dennis Ledenkof, CEO of Robosculptor In an era where technological breakthroughs reshape traditional industries, the convergence of Artificial Intelligence (AI) and robotics delivers extraordinary transformations

October 24, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.